Silverstein MicroWick.
Using the MicroWick to deliver otic medication to the inner ear fluids isa new, unique, effective, safe, efficient, and inexpensive method to treat inner ear disease. This self-treatment method using otic medication represents a major breakthrough in the treatment of inner ear disease. It allows the otologist to treat inner ear disease much as the ophthalmologist treats eye disease using eye drops. In the future, new drugs and medications will likely be developed that will relieve vertigo attacks, improve certain types of sensorineural hearing loss, and reduce tinnitus. The MicroWick will be available for patients to self-administer these medications to the inner ear through the round window membrane.
Silverstein Institute, Ear Research Foundation, 1901 Floyd Street, Sarasota, FL 34239, USA. hsilverste@aol.com
Herbert
H
Silverstein
Jack
J
Thompson
Seth I
SI
Rosenberg
Neil
N
Brown
Joshua
J
Light
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D003907:Dexamethasone / Q000008:administration & dosage*; D005839:Gentamicins / Q000008:administration & dosage*; D005938:Glucocorticoids / Q000008:administration & dosage*; D003639:Hearing Loss, Sudden / Q000188:drug therapy; D006801:Humans; D008575:Meniere Disease / Q000188:drug therapy; D011145:Polyvinyls; D012646:Self Administration / Q000295:instrumentation*; D016896:Treatment Outcome; D014432:Tympanic Membrane / Q000601:surgery
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D005938:Glucocorticoids; D011145:Polyvinyls; C013215:polyvinyl acetate; D003907:Dexamethasone